Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials
"Statins, bempedoic acid, ezetimibe, and omega-3 FAs significantly reduce serum CRP concentration, independently of LDL-C reductions."
Paper · Cardiovasc Res · 2024Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials.Chronic low-degree inflammation is a hallmark of atherosclerotic cardiovascular (CV) disease. To assess the effect of lipid-lowering therapies on C-reactive protein (CRP), a biomarker of inflammation, we conducted a meta-analysis according to the PRISMA guidelines. Databases were searched from inception to July 2023. Inclusion criteria were: (i) randomized controlled trials (RCTs) in human, Phase II, III, or IV;…academic.oup.comPS: Also consider Colchicine, GLP1-RA, low dose pioglitazone, curcumin, 4 herb synergy, milk thistle...




